you are here:

Suven Life Sciences Ltd.

BSE: 530239 | NSE: SUVEN |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE495B01038 | SECTOR: Pharmaceuticals

BSE Live

Jun 23, 16:00
91.00 -1.40 (-1.52%)
Volume
AVERAGE VOLUME
5-Day
75,260
10-Day
95,395
30-Day
84,325
37,325
  • Prev. Close

    92.40

  • Open Price

    93.95

  • Bid Price (Qty.)

    91.10 (125)

  • Offer Price (Qty.)

    93.45 (332)

NSE Live

Jun 23, 15:58
90.95 -1.60 (-1.73%)
Volume
AVERAGE VOLUME
5-Day
540,034
10-Day
736,502
30-Day
682,928
462,847
  • Prev. Close

    92.55

  • Open Price

    93.35

  • Bid Price (Qty.)

    90.95 (315)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Suven Life Sci

  • Jun 18, 2021 14:16 Source: BSE

    Suven Life Sciences - Announcement under Regulation 30 (LODR)-Newspaper Publication

    With reference to above subject, please find enclosed the copies of the newspaper advertisements, in connection with the subject referred above as required under Rule 6 (3) of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 read with the provisions of Companies Act, 2013 as appeared today i.e. June 18, 2021 in Business Standard and Nava Telangana (Telugu). The above information will also be hosted on the website of the Company at the following web link: http://www.suven.com/unpaiddividend.aspx This is for your information and record.

  • Jun 10, 2021 16:32 Source: BSE

    Suven Life Sciences - Compliances-Reg.24(A)-Annual Secretarial Compliance

    With reference to above subject, please find enclosed herewith the Annual Secretarial Compliance Report of the Company from M/s. D. Renuka, Practicing Company Secretary, for the Financial Year ended 31st March, 2021, in terms of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019.

  • May 20, 2021 14:59 Source: BSE

    Suven Life Sciences - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")

    Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of related party transactions on a consolidated basis and balances for the year ended March 31st, 2021. We request you to take this document on your record.

  • May 05, 2021 19:29 Source: BSE

    Suven Life Sciences - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdigns Pvt Ltd

  • May 05, 2021 13:04 Source: BSE

    Suven Life Sciences - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisement regarding Audited Financial Results of the Company for quarter and Financial Year ended 31st March, 2021. The advertisements are as appeared on 05th May, 2021 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at: http://www.suven.com/newspaperads.aspx This is for your information and record.

  • May 04, 2021 13:23 Source: BSE

    Suven Life Sciences - Closure Of Register Of Members & Share Transfer Books For AGM Purpose

    Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from 04th August, 2021 to 06th August, 2021 (both days inclusive) for taking record of the Members of the Company for the purpose of 32nd Annual General Meeting of the Company.

  • May 04, 2021 13:20 Source: BSE

    Suven Life Sciences - Outcome of Board Meeting (AGM on August 06, 2021)

    Suven Life Sciences Ltd has informed BSE about Outcome of Board Meeting held on May 04, 2021.

  • May 04, 2021 13:15 Source: BSE

    Suven Life Sciences - Outcome Of The Board Meeting

    With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. May 04, 2021, approved the following along with other business matters.

  • Apr 30, 2021 17:47 Source: BSE

    Suven Life Sciences - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation regarding Issued duplicate Share Certificate(s) under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received intimation from our RTA dated 30-04-2021 regarding issued duplicate share certificate(s) in lieu of the loss of original share certificate(s) to the following shareholders(s).

  • Apr 28, 2021 15:08 Source: BSE

    Suven Life Sciences - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Notice of Board Meeting - Newspaper advertisement In continuation to our letter dated April 27th, 2021 regarding the Date and Notice of Board Meeting, please find enclosed the copies of the newspaper advertisements as appeared today i.e. April 28th, 2021 in Andhra Prabha (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: http://www.suven.com/newspaperads.aspx This is for your information and record.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : May 04, 2021
Remark : Audited Results